VCYT — Veracyte Inc · P/E 47, rev $289.4M

Veracyte Inc (VCYT) is a diagnostics & research company listed on NASDAQ.

Latest reported VCYT revenue for 2026-06-30 was $289.4M. Net income was $54.2M. VCYT currently screens at market cap $4.09B and trailing P/E 47.5.

Use this VCYT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VCYT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VCYT SEC filings page. Lician reads the product cache first so this HTML stays unique to Veracyte Inc even when a live quote feed is slow.

Veracyte Inc latest statements (FY2025)

Latest cached year on this hub. Full VCYT income, balance, and cash tables.

  • Revenue$517.1M
  • Net Income$66.4M
  • Total Assets$1.41B
  • Total Debt$0
  • Free Cash Flow$126.6M

VCYT recent filings